MN

Madan Narasimhan

Active Director Director DIN 11047478
DIN 11047478 First appointment Apr 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Madan Narasimhan

Data last updated:

Madan Narasimhan is a Director at Toxel Biosciences Private Limited (since 2025). The company operates in Biotechnology.

DIN 11047478
Primary Designation Director
Industry Biotechnology
First Appointment 09 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Toxel Biosciences Private Limited U72100AP2025PTC118766
Director09 Apr 20252025Active

Board colleagues of Madan Narasimhan

Directorship timeline

Open interactive timeline →
Toxel Biosciences Private Limited
Premium access

Shareholding and investment profile for Madan Narasimhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madan Narasimhan

Madan Narasimhan currently holds 1 directorship: Toxel Biosciences Private Limited (Director, since 09 Apr 2025).

Madan Narasimhan was first appointed on 09 Apr 2025 as Director at Toxel Biosciences Private Limited.

The current boards of Madan Narasimhan's companies include Anoosha Mudur (Toxel Biosciences Private Limited), Sriakhilandeswari Akula (Toxel Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available